ACCESS CHINA FORUM 2021 @ JPM WEEK
(Shanghai, December 21, 2020) Shanghai YAFO Life Science and BioToChina.org are organizing ACCESS CHINA Forum 2021 to be held between January 4th and 22nd. As the largest China corporate access event during the JPM Conference weeks, ACCESS CHINA 2021 expects to host more than 30 keynote speakers and 100 company presentations from North America, Europe, China and Rest of Asia. We expect more than 1000 participants from China and the global biopharma industry and investment community. Over 90 global biopharma companies have confirmed presenting. 40+ presenters from China include Fosun, Tasly, Shanghai Pharma, Grand Pharma and 7 MNCs like Abbott, Bayer, MSD, BD, SERVIER, and etc.
The Forum will offer 1x1 Meeting System for pharmaceutical companies. To facilitate global partnering, ACCESS CHINA 2021 participation and presentation are FREE-OF-CHARGE. For more information and registration, please visit: www.biotochina.org.
ACCESS CHINA Forum is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.
Company roadshows are divided into ten different therapeutic areas:
● Oncology (3 sessions)
● Autoimmune Disease
● CNS / Cardiovascular
● Cell Therapy / Rare Disease
● Genitourinary / Gynecology / Pediatric
● Ophthalmology / Orthopedics
● Material / Platform Technology
● Dermatology / Respiratory / Infectious Disease
● Digestive System / Endocrinology / NASH
● IVD / Medical Devices
About YAFO LIFE SCIENCE
YAFO Life Science (YLS) is the healthcare division of YAFO Capital, which is focused on helping leading U.S. and European Biopharma & MedTech companies to successfully enter the Asian market, especially in China and Japan. YLS also helps domestic pharma companies in global business development and partnering. Along with our local partners, YLS is dedicated to bridging the gap between global medical technologies and the Asian market.
For more information about YAFO, please go to: www.yafocapital.com
BioToChina.org is the first organization to connect Pharma, Biotech & Medtech BDs in China with the rest of world. With about 500 active members in the pharma industry, BioToChina.org organizes various events (including ACCESS CHINA Forum) throughout the year to facilitate the communications of pharma BDers. For more information, please go to: www.BioToChina.org
Wendi Xiang, Vice President
YAFO Capital (Shanghai) Co. Ltd